Antenatal Iron-Folic Acid Supplementation Reduces Neonatal and Under-5 Mortality in Nepal

Research shows that antenatal iron-folic acid (IFA) supplementation improves maternal anemia and poor pregnancy outcomes, and may also have an effect on child survival. This study investigated the relative contribution of antenatal IFA supplementation on the risk of child mortality in Nepal over a 15- year period. The authors found the risk of neonatal mortality was reduced by 42 percent in children whose mothers reported taking any IFA supplements during their pregnancy.

J Nutr. 2015